CNTG Stock Performance, Insider Transaction and News

CNTG - Centogene N.V.

Market Cap	29.82M	P/E	-	EPS this Y	-29.50%	Ern Qtrly Grth	-
Income	-40.09M	Forward P/E	-1.09	EPS next Y	-	50D Avg Chg	1.00%
Sales	50.71M	PEG	-	EPS past 5Y	-	200D Avg Chg	12.00%
Dividend	N/A	Price/Book	3.98	EPS next 5Y	-	52W High Chg	-58.00%
Recommedations	2.00	Quick Ratio	1.19	Shares Outstanding	27.87M	52W Low Chg	75.00%
Insider Own	2.73%	ROA	-27.61%	Shares Float	9.60M	Beta	-0.81
Inst Own	65.25%	ROE	-1,375.33%	Shares Shorted/Prior	6.16K/11.31K	Price	1.07
Gross Margin	40.35%	Profit Margin	-77.64%	Avg. Volume	1,122,283	Target Price	1.50
Oper. Margin	-86.31%	Earnings Date	May 14	Volume	28,969	Change	5.94%

Healthcare | Diagnostics & Research | Germany

About Centogene N.V.

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Centogene N.V. News

04/02/24	CENTOGENE Receives Nasdaq Non-Compliance Notice
03/19/24	CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
02/29/24	CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
02/28/24	CENTOGENE Explores Strategic Alternatives
02/28/24	CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
01/25/24	CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
01/24/24	CENTOGENE Receives French Research Tax Credit Accreditation
01/23/24	CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
01/18/24	CENTOGENE Announces Preliminary Full Year 2023 Revenue
12/19/23	CENTOGENE Announces Voting Results of Extraordinary General Meeting
12/13/23	CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
11/28/23	CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
11/14/23	CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
10/10/23	CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
09/11/23	CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
09/07/23	CENTOGENE Reports First Half 2023 Financial Results
09/01/23	CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
08/31/23	CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
08/07/23	CENTOGENE to Participate in Upcoming Conferences in August
07/14/23	CENTOGENE Regains Compliance With Nasdaq Listing Requirements

CNTG Chatroom

History923 Posted - 11 hours ago

$CNTG Scam‼️‼️

TJU Posted - 11 hours ago

$CNTG Let's see if it pays off to have the world's 6th largest sovereign wealth fund as a partner.

History923 Posted - 12 hours ago

$CNTG 0,30 🚀‼️‼️ This Scam Company is Game Over‼️‼️ Small Insvestors Lose the Money‼️‼️

History923 Posted - 12 hours ago

$CNTG Scam‼️‼️‼️‼️

tednews Posted - 1 day ago

$CNTG 2 days ago scammer tju got happy again. thats what happened since his post: minus 23% …

TJU Posted - 2 days ago

$CNTG news Centogene N.V. has amended its loan agreement with Lifera to extend the maturity date and is negotiating potential accounts receivable financing, which is contingent on approval by senior lender Oxford Finance LLC. The firm is also exploring strategic alternatives such as mergers or additional financing, with its current cash reserves projected to last through the second quarter of 2024. Amid these developments, Centogene is delaying its Annual Report on Form 20-F filing, seeking a 15-day extension due to ongoing financial discussions. https://www.tipranks.com/news/company-announcements/centogene-n-v-explores-financial-strategies

TJU Posted - 04/30/24

$CNTG Deal?

History923 Posted - 04/25/24

$CNTG Game Over ‼️‼️‼️‼️‼️

ChiefOG Posted - 04/22/24

$CNTG 👀

History923 Posted - 04/18/24

$CNTG Scam‼️‼️‼️🇹🇷

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.!!!

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!...

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an .Scam!. This Company is Bankrupt!.

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.!!

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!..!

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.!

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!..

History923 Posted - 04/17/24

$CNTG Big Scammer Company, dont invest here!. From 2 Digits Course to Now 0,50 What an Scam!. This Company is Bankrupt!.

tednews Posted - 04/15/24

$CNTG hahaha, i thought stocksdock was already all in...

TJU Posted - 04/15/24

@stocksdog

stocksdog Posted - 04/15/24

$CNTG kind of a joke at this price. There is real value to be had in a liquidity transaction here. Time to go all in

Energy2024 Posted - 04/15/24

$CNTG very sad that things are only going downhill. I hope they can get the hang of things. but looks very, very bad.

Energy2024 Posted - 1 month ago

$CNTG Why a very large trading volume, recently. You can rate it positively or 50/50. I hope positive.

ChiefOG Posted - 1 month ago

$CNTG 🤔

tednews Posted - 1 month ago

$CNTG the fraudster and cntg insider tju always writes such empty garbage when a downward breakthrough is imminent, in this case below 60 cents. the fact that the other scammer stocksdog is also here increases the probability of this to 100%…

TJU Posted - 1 month ago

$CNTG congrats. But does it help?

Stock_Titan Posted - 1 month ago

$CNTG CENTOGENE Receives Nasdaq Non-Compliance Notice https://www.stocktitan.net/news/CNTG/centogene-receives-nasdaq-non-compliance-ynvcvd6j8jko.html

Analyst Ratings

HC Wainwright & Co.	Buy	Jun 28, 23
HC Wainwright & Co.	Buy	May 18, 23
HC Wainwright & Co.	Buy	Apr 27, 23
HC Wainwright & Co.	Buy	Apr 13, 23
HC Wainwright & Co.	Buy	Apr 12, 23
HC Wainwright & Co.	Buy	Feb 22, 23
HC Wainwright & Co.	Buy	Jan 17, 23
HC Wainwright & Co.	Buy	Nov 23, 22
SVB Leerink	Outperform	Jul 18, 22